PT Kimia Farma Tbk (IDX:KAEF)

Indonesia · Delayed Price · Currency is IDR

338.00

-20.00 (-5.59%)

Oct 30, 2026, 4:11 PM WIB

Market Cap	1.88T -44.6%
Revenue (ttm)	9.29T +5.1%
Net Income	-217.24B
EPS	n/a
Shares Out	5.57B
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,294,600
Open	360.00
Previous Close	358.00
Day's Range	334.00 - 360.00
52-Week Range	324.00 - 785.00
Beta	1.05
Analysts	n/a
Price Target	n/a
Est. Earnings	Nov 6, 2026

About PT Kimia Farma Tbk

PT Kimia Farma Tbk, together with its subsidiaries, manufactures and sells a range of medicines in Indonesia and internationally. It operates through Manufacture, Distribution, Retail, and Others segments. The company offers drugs in the form of tablets, effervescent tablets, hard and soft capsules, liquids, syrups, oral powders, non-beta-lactam external liquids, beta-lactam tablets and dry syrups, injections, ointments, creams, suppositories, semisolid dosage forms, and health supplements; traditional medicines; generic drugs, such as paraceta... [Read more]

Industry Medical Distribution

Sector Healthcare

Founded 1817

Employees 9,361

Stock Exchange Indonesia Stock Exchange

Ticker Symbol KAEF

Full Company Profile

Financial Performance

In 2025, PT Kimia Farma Tbk's revenue was 9.22 trillion, a decrease of -7.20% compared to the previous year's 9.94 trillion. Losses were -334.96 billion, -60.23% less than in 2024.

Financial Statements